COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

Milestone Node

Purpose of Study

Determine whether etripamil nasal spray 70mg is superior to placebo at terminating episodes of PSVT in an outpatient setting

Trial Status

In follow up

Eligibility Criteria

18 years or older, documented history of PSVT, women of childbearing potential who are sexually active must agree to use highly effective form of contraception

Duration of Participation

Until the subject has a PSVT episode and take the study drug, or until at least 100 other subjects have a PSVT episode and take the study drug

Contact Name: Sara Burg, RN

Contact Phone: 515-633-3845

Contact Email: scburg@iowaheart.com